1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-1491.
2. Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology 2016;150:1393-1407.
3. Quigley EM, Abdel-Hamid H, Barbara G, et al. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol 2012;46:356-366.
5. Thumshirn M, Camilleri M, Hanson RB, Williams DE, Schei AJ, Kammer PP. Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol 1998;275-G314-G321.
6. Heymen S, Wexner SD, Gulledge AD. MMPI assessment of patients with functional bowel disorders. Dis Colon Rectum 1993;36:593-596.
8. Butcher JN, Dahlstrom WG, Graham JR, Tellegen A, Kaemmer B. The Minnesota Multiphasic Personality Inventory-2 (MMPI2): manual for administration and scoring. Minneapolis: University of Minnesota Press, 1989.
9. Engel GL. The need for a new medical model: a challenge for biomedicine. Psychodyn Psychiatry 2012;40:377-396.
10. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390.
11. Drossman DA, Chang L. Psychosocial factors in the care of patients with GI disorders. In: Yamada T. eds. Textbook of gastroenterology. Philadelphia: Lippincott-Raven, 2003:636-654.
13. Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome: a multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95:701-708.
14. Camilleri M, Vazquez-Roque M, Iturrino J, et al. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2012;303-G120-G128.
15. Whitehead WE; Validation Working Team in Association with the Rome Questionnaire Committee. Development and validation of the Rome III diagnostic questionnaire. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome III: the functional gastrointestinal disorders. McLean: Degnon Associates, 2006:835-865.
16. Galmiche JP, Clouse RE, Bálint A, et al. Functional esophageal disorders. Gastroenterology 2006;130:1459-1465.
17. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479.
18. Bharucha AE, Wald A, Enck P, Rao S. Functional anorectal disorders. Gastroenterology 2006;130:1510-1518.
19. Clouse RE, Mayer EA, Aziz Q, et al. Functional abdominal pain syndrome. Gastroenterology 2006;130:1492-1497.
20. Bouchoucha M, Girault-Lidvan N, Hejnar M, Mary F, Airinei G, Benamouzig R. Clinical and psychological characteristics of patients with globus. Clin Res Hepatol Gastroenterol 2019;43:614-622.
21. Graham JR. MMPI-2: assessing personality and psychopathology. New York: Oxford University Press, 2011.
23. Duleba AJ, Jubanyik KJ, Greenfeld DA, Olive DL. Changes in personality profile associated with laparoscopic surgery for chronic pelvic pain. J Am Assoc Gynecol Laparosc 1998;5:389-395.
24. Keye WR Jr. General evaluation of premenstrual symptoms. Clin Obstet Gynecol 1987;30:396-407.
25. Richter JE. Stress and psychologic and environmental factors in functional dyspepsia. Scand J Gastroenterol Suppl 1991;182:40-46.
27. Blanchard EB, Keefer L, Galovski TE, Taylor AE, Turner SM. Gender differences in psychological distress among patients with irritable bowel syndrome. J Psychosom Res 2001;50:271-275.
28. Lee CT, Chuang TY, Lu CL, Chen CY, Chang FY, Lee SD. Abnormal vagal cholinergic function and psychological behaviors in irritable bowel syndrome patients: a hospital-based Oriental study. Dig Dis Sci 1998;43:1794-1799.
29. Tosic-Golubovic S, Miljkovic S, Nagorni A, Lazarevic D, Nikolic G. Irritable bowel syndrome, anxiety, depression and personality characteristics. Psychiatr Danub 2010;22:418-424.
30. Whitehead WE, Crowell MD. Psychologic considerations in the irritable bowel syndrome. Gastroenterol Clin North Am 1991;20:249-267.
31. Brown TA, Sellbom M. The utility of the MMPI-2-RF validity scales in detecting underreporting. J Pers Assess 2020;102:66-74.
32. Leonelli BT, Chang CH, Bock RD, Schilling SG. Interpretation of a full-information item-level factor analysis of the MMPI-2: normative sampling and nonpathognomonic descriptors. J Pers Assess 2000;74:400-422.
34. Bouchoucha M, Hejnar M, Devroede G, Boubaya M, Bon C, Benamouzig R. Patients with irritable bowel syndrome and constipation are more depressed than patients with functional constipation. Dig Liver Dis 2014;46:213-218.
35. Mousavinasab SM, Gorganinezhad-Moshiri M, Saberifirouzi M, Dehbozorgi G, Mehrabani D. Personality characteristics and irritable bowel syndrome in Shiraz, southern Iran. Saudi J Gastroenterol 2007;13:168-171.
36. Miller V, Whitaker K, Morris JA, Whorwell PJ. Gender and irritable bowel syndrome: the male connection. J Clin Gastroenterol 2004;38:558-560.
37. Patel P, Bercik P, Morgan DG, et al. Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating. Aliment Pharmacol Ther 2015;41:449-458.
38. Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995;109:671-680.
39. Cremonini F, Talley NJ. Review article: the overlap between functional dyspepsia and irritable bowel syndrome. A tale of one or two disorders? Aliment Pharmacol Ther 2004;20 Suppl 7:40-49.
40. Walker EA, Roy-Byrne PP, Katon WJ. Irritable bowel syndrome and psychiatric illness. Am J Psychiatry 1990;147:565-572.
41. Talley NJ. Antidepressants in IBS: are we deluding ourselves? Am J Gastroenterol 2004;99:921-923.
43. Bouchoucha M, Devroede G, Fysekidis M, Rompteaux P, Sabate JM, Benamouzig R. Data mining approach for the characterization of functional bowel disorders according to symptom intensity provides a small number of homogenous groups. Dig Dis 2020;38:310-319.